I have been in a long time - from before 2013. But luckily the bulk of my holding was acquired around the lows later on. I still hold warrants at near the low that will not expire for a while. While I have been exhausted by the continued delays, adding steps, moving the goal posts, the changing of my expectations to times further out, but I now do believe we are truly near the end of all this with the MAA and MA that are both around the corner and could drop at any moment. The points I ponder the most at this time are, 1) will they only file in the UK for the MAA or will they go with some means of filing in multiple jurisdictions in parallel (eg ORBIS), 1a) it would be nice to know if they are doing a rolling submission, but we will know this fairly soon, 2) will they be able to file not only for glio (n & r), or will they try to use the notion of tissue and/or tumor agnostic, and file for multiple cancers at one time? Glio is a given in my book that just needs a little time to play out. 3) how the spoofing case proceeds and whether there will be a settlement in the short term or a trial in the long term. 4) Whether and when the spoofing trial will be expanded to include naked short selling and other manipulations, and 5) what is happening on the BO or partnership fronts, 6) when we eventually uplist, but this is low on the totem pole of concerns.
